close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Hantavirus outbreak isn't another Covid pandemic – but experts say it's testing U.S. readiness
Tags US: News Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Inside India newsletter: Trump-Xi meeting could test India’s positioning as China counterweight
Tickers RH
Tags iShares MSCI India ETF Social media WisdomTree India Earnings Fund
From CNBC.com News
Healthy Returns: Novo Nordisk says high-dose Wegovy helped some patients lose nearly 28% of their weight
Tags Health & Science Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Hims & Hers plummets 16% after first-quarter loss, weak earnings guidance
Tags US: News Business News Europe News
From CNBC.com News
Asia's trillion-dollar titans are powering — and distorting — its fastest growing stock markets
Tags Asia: Markets iShares MSCI Taiwan ETF Asia News
From CNBC.com News
Global week ahead: Crude diplomacy casts shadow over Trump-Xi summit
Tags Vanguard FTSE Europe Index Fund ETF Shares China Automotive Systems Inc iShares MSCI France ETF
From CNBC.com News
CNBC Daily Open: Leadership challenge swirls around Starmer
Tags Asia Markets McDonald's Corp Foreign policy
From CNBC.com News
Healthy Returns: First Ozempic generics in Canada will be a test case for Novo Nordisk
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Health & Science
From CNBC.com News
CNBC Daily Open: Iran reviews 'one-page peace plan'
Tags World Markets Alphabet Class A Palantir Technologies Inc
From CNBC.com News
Inside India newsletter: Social media is reshaping the world's fastest-growing market for global brands
Tickers RH
Tags iShares MSCI India ETF Social media WisdomTree India Earnings Fund
From CNBC.com News
Novo Nordisk CEO says the drugmaker is more active than ever in seeking out deals
Tags Health & Science Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Wegovy sales smash forecasts after pill launch as Novo Nordisk hikes guidance
Tags Business News Earnings Business
From CNBC.com News
European stocks set to rise as oil prices fall after Trump signals Iran war de-escalation
Tags Europe Economy World Economy Novo Nordisk A/S
From CNBC.com News
CNBC Daily Open: Kospi bull run rolls on
Tags Pinterest Inc Paramount Skydance Corp Novo Nordisk A/S
From CNBC.com News
Iran tensions, Palantir earnings, Musk's SEC settlement and more in Morning Squawk
Tags Procter & Gamble Co American Eagle Outfitters Inc Markets
From CNBC.com News
Novo Nordisk’s Wegovy pill head start forces investors to rethink Eli Lilly's GLP-1 dominance
Tags Health & Science Novo Nordisk A/S LifeMD Inc
From CNBC.com News
'Bubble effect': Weight loss drug fueled growth is putting the pharma sector at risk, report finds
Tags Novo Nordisk A/S iShares Biotechnology ETF Biotech and Pharmaceuticals
From CNBC.com News
CNBC Daily Open: As Gulf fatigue sets in, earnings take center stage
Tags Novo Nordisk A/S Daily Open eBay Inc
From CNBC.com News
Global week ahead: Is 'Sell in May' just a myth?
Tags HSBC Holdings PLC Ferrari NV iShares Global Energy ETF
From CNBC.com News
Weight loss and hair loss: The growing hair treatment market from GLP-1s
Tags Business Ulta Beauty Inc Business News
From CNBC.com News
Apple earnings, DHS shutdown, 'Ozempic breath' and more in Morning Squawk
Tags Caterpillar Inc Markets Investing
From CNBC.com News
Healthy Returns: Eli Lilly’s chief scientific officer breaks down the latest obesity pill data
Tags Health care industry Eli Lilly and Co Biotech and Pharmaceuticals
From CNBC.com News
Eli Lilly’s weight loss pill orforglipron clears its latest trial, paving way for approval
Tags US: News Business News Companies
From CNBC.com News
A world on weight loss drugs: How GLP-1s are reshaping the economy
Tags Economy Hotels and Leisure AstraZeneca PLC
From CNBC.com News
Eli Lilly's obesity pill remains a viable rival to Novo's oral Wegovy despite data that underwhelmed investors
Tags Business Companies Roche Holding AG
From CNBC.com News
FDA approves first-ever glucose monitoring system for weight loss from Signos
Tags Business News Business Companies
From CNBC.com News
Viking Therapeutics shares fall more than 30% on disappointing obesity pill trial data
Tags Business Companies Business News
From CNBC.com News
Home Depot disappoints, Novo Nordisk's GLP-1 updates, an AI warning and more in Morning Squawk
Tags Novo Nordisk A/S Personnel Lowe's Companies Inc
From CNBC.com News
Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients
Tags Pharmaceuticals Eli Lilly and Co Health care industry
From CNBC.com News
5 things to know before the Thursday open: Chip tariffs | Cook's White House visit | Wall Street's fashionista
Tags Economy McDonald's Corp Dine Brands Global
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today